Abstract
Cefpirome (CPR), a new injectable cephem antibiotic, was administered to 12 patients with obstetric and gynecological infections and the following results were obtained.
The clinical response was evaluated as excellent in 2 and good in 10 cases and the overall efficacy rate was 100%.
Bacteriologically, eleven organisms were isolated from eight patients and the eradication rate was 64%.
No side effects were observed in any of the cases treated with CPR.
